title: Current status of HIV therapy: II. Opportunistic diseases.
abstract: Infections and malignancies account for most deaths in patients with AIDS and will continue to do so as long as HIV-induced immunosuppression is progressive and irreversible. Co-trimoxazole has emerged as the preferred agent for prevention of Pneumocystis carinii pneumonia. As appropriate broad-spectrum agents are developed, multiple opportunistic pathogen prophylaxis could become effective.
authors.affiliation: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore.
authors.forename: J
authors.initials: J
authors.lastname: Feinberg
authors.forename: D F
authors.initials: DF
authors.lastname: Hoth
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000276:immunology; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D009894:Opportunistic Infections / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D015996:Survival Rate